Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1932 1
1948 1
1953 1
1963 1
1964 2
1973 1
1975 1
1976 5
1977 5
1978 2
1979 3
1980 2
1981 1
1982 2
1983 2
1984 3
1985 2
1986 2
1987 1
1988 5
1989 5
1990 2
1991 3
1992 3
1993 5
1994 6
1995 6
1996 7
1997 6
1998 4
1999 9
2000 9
2001 5
2002 12
2003 5
2004 7
2005 8
2006 9
2007 11
2008 18
2009 16
2010 12
2011 20
2012 15
2013 12
2014 7
2015 6
2016 4
2017 2
2018 5
2019 8
2020 6
2021 3
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
Perkins GD, Ji C, Connolly BA, Couper K, Lall R, Baillie JK, Bradley JM, Dark P, Dave C, De Soyza A, Dennis AV, Devrell A, Fairbairn S, Ghani H, Gorman EA, Green CA, Hart N, Hee SW, Kimbley Z, Madathil S, McGowan N, Messer B, Naisbitt J, Norman C, Parekh D, Parkin EM, Patel J, Regan SE, Ross C, Rostron AJ, Saim M, Simonds AK, Skilton E, Stallard N, Steiner M, Vancheeswaran R, Yeung J, McAuley DF; RECOVERY-RS Collaborators. Perkins GD, et al. JAMA. 2022 Feb 8;327(6):546-558. doi: 10.1001/jama.2022.0028. JAMA. 2022. PMID: 35072713 Free PMC article. Clinical Trial.
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Yousuf AJ, Mohammed S, Carr L, Yavari Ramsheh M, Micieli C, Mistry V, Haldar K, Wright A, Novotny P, Parker S, Glover S, Finch J, Quann N, Brookes CL, Hobson R, Ibrahim W, Russell RJ, John C, Grimbaldeston MA, Choy DF, Cheung D, Steiner M, Greening NJ, Brightling CE. Yousuf AJ, et al. Among authors: russell rj. Lancet Respir Med. 2022 May;10(5):469-477. doi: 10.1016/S2213-2600(21)00556-7. Epub 2022 Mar 24. Lancet Respir Med. 2022. PMID: 35339234 Clinical Trial.
Cough and Eosinophilia.
Diver S, Russell RJ, Brightling CE. Diver S, et al. Among authors: russell rj. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1740-1747. doi: 10.1016/j.jaip.2019.04.048. J Allergy Clin Immunol Pract. 2019. PMID: 31279462 Review.
Response.
Hill AT, Gold PM, El Solh AA, Metlay JP, Ireland B, Irwin RS; CHEST Expert Cough Panel. Hill AT, et al. Chest. 2019 May;155(5):1082-1083. doi: 10.1016/j.chest.2019.02.014. Chest. 2019. PMID: 31060697 No abstract available.
DISCUSSION.
Russell RJ. Russell RJ. Science. 1932 Jun 3;75(1953):583-5. doi: 10.1126/science.75.1953.583. Science. 1932. PMID: 17740405 No abstract available.
New and emerging drug treatments for severe asthma.
Diver S, Russell RJ, Brightling CE. Diver S, et al. Among authors: russell rj. Clin Exp Allergy. 2018 Mar;48(3):241-252. doi: 10.1111/cea.13086. Epub 2018 Feb 13. Clin Exp Allergy. 2018. PMID: 29315966 Review.
289 results